Showing results (61-70 of 227) with videos related to

Sort By:
Pageof 23
Trends in Cancer|February 14, 2024
Targeting solid tumor antigens with chimeric receptors: cancer biology meets synthetic immunologyGabriele J Kembuan, Joanna Y Kim, Marcela V Maus, et al.
Immunological Reviews|September 11, 2023
"Hurdles race for CAR T-cell therapy in digestive tract cancer"Marie-Noelle Kronig, Marc Wehrli, Diego Salas-Benito, et al.
Antibodies (Basel, Switzerland)|June 1, 2022
Advances in Chimeric Antigen Receptor (CAR) T-Cell Therapies for the Treatment of Primary Brain TumorsChristopher W Mount, Luis Nicolas Gonzalez Castro
The Journal of Biological Chemistry|October 20, 2019
Glycoengineering of chimeric antigen receptor (CAR) T-cells to enforce E-selectin bindingNandini Mondal, Mariana Silva, Ana P Castano, et al.
Science (New York, N.Y.)|November 24, 2022
The future of engineered immune cell therapiesDarrell J Irvine, Marcela V Maus, David J Mooney, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 18, 2018
Immunotherapy for Glioblastoma: Adoptive T-cell StrategiesBryan D Choi, Marcela V Maus, Carl H June, et al.
Blood|March 1, 2014
Antibody-modified T cells: CARs take the front seat for hematologic malignanciesMarcela V Maus, Stephan A Grupp, David L Porter, et al.
Neurosurgical Focus|June 2, 2018
Chimeric antigen receptor T-cell immunotherapy for glioblastoma: practical insights for neurosurgeonsBryan D Choi, William T Curry, Bob S Carter, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|December 14, 2019
Dynamic Profiling of Antitumor Activity of CAR T Cells Using Micropatterned Tumor ArraysXiao Wang, Irene Scarfò, Andrea Schmidts, et al.
European Journal of Immunology|December 31, 2022
Four challenges to CAR T cells breaking the glass ceilingStefanie R Bailey, Trisha R Berger, Charlotte Graham, et al.
Pageof 23